Familial cystic parathyroid adenomatosis
- PMID: 3592449
- DOI: 10.7326/0003-4819-107-1-54
Familial cystic parathyroid adenomatosis
Abstract
Although the commonest familial form of primary hyperparathyroidism is parathyroid hyperplasia, a few families have manifested parathyroid adenomas. We describe a family in which four members developed cystic parathyroid adenomas. Although calcium levels returned to normal after resection of the adenoma, a second adenoma would often develop several years later (we have termed this temporal sequence adenomatosis). Each adenoma had a cystic histologic appearance, and three of four normal-sized parathyroid glands also contained many cysts. No other endocrine tumors have appeared, but in three patients the hyperparathyroidism was complicated by fibrous maxillary or mandibular tumors that resembled ossifying fibromas rather than the brown tumors generally found in patients with hyperparathyroidism. Each patient with an adenoma was hypercalciuric, but two were obligate carriers of hypocalciuric hypercalcemia. This familial occurrence of the rare cystic parathyroid adenoma suggests the presence of a distinct hereditary syndrome. The genetic basis may be the simultaneous inheritance of familial hypocalciuric hypercalcemia and another trait that may increase the urinary excretion of calcium.
Similar articles
-
Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.J Oral Maxillofac Surg. 2015 Jan;73(1):194.e1-9. doi: 10.1016/j.joms.2014.09.008. Epub 2014 Sep 28. J Oral Maxillofac Surg. 2015. PMID: 25511968 Review.
-
Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia).Am J Med. 1984 Jun;76(6):1021-6. doi: 10.1016/0002-9343(84)90852-0. Am J Med. 1984. PMID: 6731460
-
Familial isolated hyperparathyroidism due to multiple adenomas associated with ossifying jaw fibroma and multiple uterine adenomyomatous polyps.Eur J Endocrinol. 1998 May;138(5):557-61. doi: 10.1530/eje.0.1380557. Eur J Endocrinol. 1998. PMID: 9625369
-
Molecular pathogenesis of parathyroid tumours.Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):891-908. doi: 10.1016/j.beem.2018.11.001. Epub 2018 Nov 20. Best Pract Res Clin Endocrinol Metab. 2018. PMID: 30477753 Review.
-
Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager.Eur J Endocrinol. 2009 Jul;161(1):207-10. doi: 10.1530/EJE-09-0257. Epub 2009 May 7. Eur J Endocrinol. 2009. PMID: 19423559
Cited by
-
Parathyroid carcinoma.J Bone Miner Res. 2008 Dec;23(12):1869-80. doi: 10.1359/jbmr.081018. J Bone Miner Res. 2008. PMID: 19016595 Free PMC article. Review. No abstract available.
-
Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.Endocr Relat Cancer. 2010 May 18;17(2):513-24. doi: 10.1677/ERC-09-0272. Print 2010 Jun. Endocr Relat Cancer. 2010. PMID: 20304979 Free PMC article.
-
CDC73 c.1155-3A>G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome.JBMR Plus. 2024 Nov 19;9(1):ziae149. doi: 10.1093/jbmrpl/ziae149. eCollection 2025 Jan. JBMR Plus. 2024. PMID: 39677927 Free PMC article.
-
The EIF4EBP3 translational repressor is a marker of CDC73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.Cell Death Dis. 2012 Feb 2;3(2):266. doi: 10.1038/cddis.2012.6. Cell Death Dis. 2012. PMID: 22297294 Free PMC article.
-
Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature.Int J Endocrinol. 2019 Dec 18;2019:1761030. doi: 10.1155/2019/1761030. eCollection 2019. Int J Endocrinol. 2019. PMID: 31929790 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources